Related Experiment Videos
Nrf2 in health and disease: current and future clinical implications
Othman Al-Sawaf1, Tim Clarner2, Athanassios Fragoulis3
1Department of Anatomy and Cell Biology, University Hospital, RWTH Aachen University, Aachen, Germany othman.al-sawaf@rwth-aachen.de cwruck@ukaachen.de.
Abstract:
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a major regulator of oxidative stress defence in the human body. As Nrf2 regulates the expression of a large battery of cytoprotective genes, it plays a crucial role in the prevention of degenerative disease in multiple organs. Thus it has been the focus of research as a pharmacological target that could be used for prevention and treatment of chronic diseases such as multiple sclerosis, chronic kidney disease or cardiovascular diseases. The present review summarizes promising findings from basic research and shows which Nrf2-targeting therapies are currently being investigated in clinical trials and which agents have already entered clinical practice.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) is key to cellular defense against oxidative stress. This review covers Nrf2-targeting therapies for chronic diseases, including those in clinical trials and practice.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of the antioxidant response.
- Nrf2 controls a vast network of cytoprotective genes essential for preventing organ damage.
- Dysregulation of Nrf2 is implicated in various chronic and degenerative diseases.
Purpose of the Study:
- To review the role of Nrf2 in oxidative stress and disease prevention.
- To summarize Nrf2-targeting therapies currently in clinical trials.
- To highlight Nrf2-modulating agents that have reached clinical practice.
Main Methods:
- Literature review of basic research findings on Nrf2.
- Analysis of ongoing clinical trials targeting Nrf2.
- Survey of approved Nrf2-based therapies.
Main Results:
- Nrf2 activation demonstrates therapeutic potential across multiple organ systems.
- Several Nrf2-targeting drugs are progressing through clinical trials for conditions like multiple sclerosis, kidney disease, and cardiovascular diseases.
- Some Nrf2-modulating agents are already in clinical use, demonstrating the translational success of targeting this pathway.
Conclusions:
- Nrf2 is a critical therapeutic target for managing oxidative stress-related chronic diseases.
- The development of Nrf2-targeting therapies represents a significant advancement in preventative and therapeutic medicine.
- Further research and clinical investigation into Nrf2 modulation promise new treatments for a range of debilitating conditions.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
NF-kB-dependent Signaling Pathway
Microorganisms in Medicine and Therapeutics